| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Cost-effectiveness Analysis of Systemic Therapy for Metastatic Hormone-sensitive Prostate Cancer
|
Sathianathen, Niranjan J.
|
|
|
|
6 |
p. 649-655
|
artikel
|
| 2 |
Active Surveillance for Intermediate-risk Prostate Cancer: A Systematic Review, Meta-analysis, and Metaregression
|
Baboudjian, Michael
|
|
|
|
6 |
p. 617-627
|
artikel
|
| 3 |
Addition of Docetaxel to First-line Long-term Hormone Therapy in Prostate Cancer (STAMPEDE): Modelling to Estimate Long-term Survival, Quality-adjusted Survival, and Cost-effectiveness
|
Woods, Beth S.
|
|
|
|
6 |
p. 449-458
|
artikel
|
| 4 |
Adjuvant Systemic Therapy for High-risk Muscle-invasive Bladder Cancer After Radical Cystectomy: Current Options and Future Opportunities
|
Mir, M. Carmen
|
|
|
|
6 |
p. 726-731
|
artikel
|
| 5 |
Adjuvant Therapy in Nonmetastatic High-risk Kidney Cancer: Importance of the Timing of Postnephrectomy Imaging and Treatment Delivery
|
Capitanio, Umberto
|
|
|
|
6 |
p. 538-539
|
artikel
|
| 6 |
A Multivariable Approach Using Magnetic Resonance Imaging to Avoid a Protocol-based Prostate Biopsy in Men on Active Surveillance for Prostate Cancer—Data from the International Multicenter Prospective PRIAS Study
|
Luiting, Henk Benjamin
|
|
|
|
6 |
p. 651-658
|
artikel
|
| 7 |
A Novel Classification Proposal for Rectourethral Fistulas After Primary Treatment of Prostate Cancer
|
Martini, Alberto
|
|
|
|
6 |
p. 510-511
|
artikel
|
| 8 |
A Novel Risk-based Approach Simulating Oncological Surveillance After Radical Nephroureterectomy in Patients with Upper Tract Urothelial Carcinoma
|
Shigeta, Keisuke
|
|
|
|
6 |
p. 756-763
|
artikel
|
| 9 |
Building an Understanding of the Value of Docetaxel Plus Hormone Therapy in Prostate Cancer: An Ever-growing Evidence Base
|
De Abreu Lourenco, Richard
|
|
|
|
6 |
p. 459-460
|
artikel
|
| 10 |
Can Patients with Muscle-invasive Bladder Cancer and Fibroblast Growth Factor Receptor-3 Alterations Still Be Considered for Neoadjuvant Pembrolizumab? A Comprehensive Assessment from the Updated Results of the PURE-01 Study
|
Necchi, Andrea
|
|
|
|
6 |
p. 1001-1005
|
artikel
|
| 11 |
Clinical Utility of Cell-free and Circulating Tumor DNA in Kidney and Bladder Cancer: A Critical Review of Current Literature
|
Green, Elizabeth A.
|
|
|
|
6 |
p. 893-903
|
artikel
|
| 12 |
Combined Use of Prostate-specific Antigen Density and Magnetic Resonance Imaging for Prostate Biopsy Decision Planning: A Retrospective Multi-institutional Study Using the Prostate Magnetic Resonance Imaging Outcome Database (PROMOD)
|
Falagario, Ugo Giovanni
|
|
|
|
6 |
p. 971-979
|
artikel
|
| 13 |
Comparative Effectiveness Analysis of Treatment Strategies for Surgically Resectable Neuroendocrine Carcinoma of the Urinary Tract
|
Alhalabi, Omar
|
|
|
|
6 |
p. 611-620
|
artikel
|
| 14 |
Comparison of Magnetic Resonance Imaging-stratified Clinical Pathways and Systematic Transrectal Ultrasound-guided Biopsy Pathway for the Detection of Clinically Significant Prostate Cancer: A Systematic Review and Meta-analysis of Randomized Controlled Trials
|
Woo, Sungmin
|
|
|
|
6 |
p. 605-616
|
artikel
|
| 15 |
Complications and Adverse Events of Three Magnetic Resonance Imaging–based Target Biopsy Techniques in the Diagnosis of Prostate Cancer Among Men with Prior Negative Biopsies: Results from the FUTURE Trial, a Multicentre Randomised Controlled Trial
|
Wegelin, Olivier
|
|
|
|
6 |
p. 617-624
|
artikel
|
| 16 |
Contents
|
|
|
|
|
6 |
p. iii-v
|
artikel
|
| 17 |
Contents
|
|
|
|
|
6 |
p. iii-vi
|
artikel
|
| 18 |
Contents
|
|
|
|
|
6 |
p. iii-v
|
artikel
|
| 19 |
Contents
|
|
|
|
|
6 |
p. iii-iv
|
artikel
|
| 20 |
Contents
|
|
|
|
|
6 |
p. iii-v
|
artikel
|
| 21 |
Contents
|
|
|
|
|
6 |
p. iii-iv
|
artikel
|
| 22 |
Corrigendum to ‘Diagnostic Performance of Vesical Imaging Reporting and Data System for the Prediction of Muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis’ [European Urology Oncology 3 (2020) 306-315]
|
Woo, Sungmin
|
|
|
|
6 |
p. 811
|
artikel
|
| 23 |
Corrigendum to “Proposal for a Novel Histological Scoring System as a Potential Grading Approach for Muscle-invasive Urothelial Bladder Cancer Correlating with Disease Aggressiveness and Patient Outcomes” [European Urology Oncology (2023)]
|
Eckstein, Markus
|
|
|
|
6 |
p. 641
|
artikel
|
| 24 |
Cutting-edge Management of Muscle-invasive Bladder Cancer in 2020 and a Glimpse into the Future
|
Vetterlein, Malte W.
|
|
|
|
6 |
p. 789-801
|
artikel
|
| 25 |
Cytoreductive Nephrectomy in Metastatic Papillary Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium
|
Graham, Jeffrey
|
|
|
|
6 |
p. 643-648
|
artikel
|
| 26 |
Development and External Validation of a Novel Nomogram to Predict the Probability of Pelvic Lymph-node Metastases in Prostate Cancer Patients Using Magnetic Resonance Imaging and Molecular Imaging with Prostate-specific Membrane Antigen Positron Emission Tomography
|
Vis, André N.
|
|
|
|
6 |
p. 553-563
|
artikel
|
| 27 |
Development and Validation of an Improved Pathological Nodal Staging System for Urothelial Carcinoma of the Bladder
|
Patel, Devin N.
|
|
|
|
6 |
p. 656-663
|
artikel
|
| 28 |
Diagnostic Accuracy of Novel Urinary Biomarker Tests in Non–muscle-invasive Bladder Cancer: A Systematic Review and Network Meta-analysis
|
Laukhtina, Ekaterina
|
|
|
|
6 |
p. 927-942
|
artikel
|
| 29 |
Diagnostic Accuracy of Single-plane Biparametric and Multiparametric Magnetic Resonance Imaging in Prostate Cancer: A Randomized Noninferiority Trial in Biopsy-naïve Men
|
Russo, Filippo
|
|
|
|
6 |
p. 855-862
|
artikel
|
| 30 |
Digital Rectal Examination Is Not a Useful Screening Test for Prostate Cancer
|
Krilaviciute, Agne
|
|
|
|
6 |
p. 566-573
|
artikel
|
| 31 |
Do Learning Disabilities Affect Testicular Cancer Survival: A National Cohort Study Between 2001 and 2015
|
Afshar, Mehran
|
|
|
|
6 |
p. 773-779
|
artikel
|
| 32 |
Early Tolerance and Tumor Control Outcomes with High-dose Ultrahypofractionated Radiation Therapy for Prostate Cancer
|
Zelefsky, Michael J.
|
|
|
|
6 |
p. 748-755
|
artikel
|
| 33 |
Editorial Board
|
|
|
|
|
6 |
p. i-ii
|
artikel
|
| 34 |
Editorial Board
|
|
|
|
|
6 |
p. i-ii
|
artikel
|
| 35 |
Editorial Board
|
|
|
|
|
6 |
p. i-ii
|
artikel
|
| 36 |
Editorial Board
|
|
|
|
|
6 |
p. i-ii
|
artikel
|
| 37 |
Editorial Board
|
|
|
|
|
6 |
p. i-ii
|
artikel
|
| 38 |
Editorial Board
|
|
|
|
|
6 |
p. i-ii
|
artikel
|
| 39 |
Epidemiology and Prevention of Prostate Cancer
|
Gandaglia, Giorgio
|
|
|
|
6 |
p. 877-892
|
artikel
|
| 40 |
Epidemiology, Screening, and Prevention of Bladder Cancer
|
Lobo, Niyati
|
|
|
|
6 |
p. 628-639
|
artikel
|
| 41 |
Equity in Drug Accessibility: The Surprising Case of Treatments for Metastatic Castration-sensitive Prostate Cancer in European Countries
|
Caffo, Orazio
|
|
|
|
6 |
p. 1011-1012
|
artikel
|
| 42 |
Familial Urinary Bladder Cancer with Other Cancers
|
Yu, Hongyao
|
|
|
|
6 |
p. 461-466
|
artikel
|
| 43 |
Fast Magnetic Resonance Imaging as a Viable Method for Directing the Prostate Cancer Diagnostic Pathway
|
Padhani, Anwar R.
|
|
|
|
6 |
p. 863-865
|
artikel
|
| 44 |
First-line Treatment of Metastatic Renal Cell Carcinoma: A Systematic Review and Network Meta-analysis
|
Hahn, Andrew W.
|
|
|
|
6 |
p. 708-715
|
artikel
|
| 45 |
From Clinical Trials to Real-life Clinical Practice: The Role of Immunotherapy with PD-1/PD-L1 Inhibitors in Advanced Urothelial Carcinoma
|
Hussain, Syed A.
|
|
|
|
6 |
p. 486-500
|
artikel
|
| 46 |
Genomic Risk Predicts Molecular Imaging-detected Metastatic Nodal Disease in Prostate Cancer
|
Xu, Melody J.
|
|
|
|
6 |
p. 685-690
|
artikel
|
| 47 |
Germline Variants Identified in Patients with Early-onset Renal Cell Carcinoma Referred for Germline Genetic Testing
|
Truong, Hong
|
|
|
|
6 |
p. 993-1000
|
artikel
|
| 48 |
Head-to-Head Comparison of 18F-PSMA-1007 Positron Emission Tomography/Computed Tomography and Multiparametric Magnetic Resonance Imaging with Whole-mount Histopathology as Reference in Localisation and Staging of Primary Prostate Cancer
|
Exterkate, Leonie
|
|
|
|
6 |
p. 574-581
|
artikel
|
| 49 |
Hereditary Leiomyomatosis and Renal Cell Cancer: Clinical, Molecular, and Screening Features in a Cohort of 185 Affected Individuals
|
Forde, Claire
|
|
|
|
6 |
p. 764-772
|
artikel
|
| 50 |
Identification of the Optimal Candidates for Nodal Staging with Extended Pelvic Lymph Node Dissection Among Prostate Cancer Patients Who Underwent Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography. External Validation of the Memorial Sloan Kettering Cancer Center and Briganti Nomograms and Development of a Novel Tool
|
Gandaglia, Giorgio
|
|
|
|
6 |
p. 543-552
|
artikel
|
| 51 |
Immune Biomarkers in Metastatic Castration-resistant Prostate Cancer
|
Fenor de la Maza, María Dolores
|
|
|
|
6 |
p. 659-667
|
artikel
|
| 52 |
Immune Checkpoint Inhibitors in Front-line Therapy for Urothelial Cancer
|
Szabados, Bernadett
|
|
|
|
6 |
p. 943-947
|
artikel
|
| 53 |
Impact of Hospital Case Volume on Outcomes Following Radical Nephrectomy and Inferior Vena Cava Thrombectomy
|
Freifeld, Yuval
|
|
|
|
6 |
p. 691-698
|
artikel
|
| 54 |
Impact of Hypofractionated Radiotherapy on Patient-reported Outcomes in Prostate Cancer: Results up to 5 yr in the CHHiP trial (CRUK/06/016)
|
Staffurth, John N.
|
|
|
|
6 |
p. 980-992
|
artikel
|
| 55 |
Incidence, Risk Factors, and Outcomes for Rectal Injury During Radical Prostatectomy: A Population-based Study
|
Barashi, Nimrod S.
|
|
|
|
6 |
p. 501-506
|
artikel
|
| 56 |
Is There an Impact of Transperineal Versus Transrectal Magnetic Resonance Imaging–targeted Biopsy in Clinically Significant Prostate Cancer Detection Rate? A Systematic Review and Meta-analysis
|
Uleri, Alessandro
|
|
|
|
6 |
p. 621-628
|
artikel
|
| 57 |
Long-term Outcomes for Men in a Prostate Screening Trial with an Initial Benign Prostate Biopsy: A Population-based Cohort
|
Palmstedt, Emmeli
|
|
|
|
6 |
p. 716-722
|
artikel
|
| 58 |
Magnetic Resonance Imaging/Ultrasound Fusion-guided Transperineal Versus Magnetic Resonance Imaging/Ultrasound Fusion-guided Transrectal Prostate Biopsy—A Systematic Review
|
Rai, Bhavan Prasad
|
|
|
|
6 |
p. 904-913
|
artikel
|
| 59 |
Management of Local Kidney Cancer Relapse
|
Zlatev, Dimitar V.
|
|
|
|
6 |
p. 524
|
artikel
|
| 60 |
Multiparametric Magnetic Resonance Imaging Cost-effectiveness in Active Surveillance: More a Belief than Evidence
|
Mottet, Nicolas
|
|
|
|
6 |
p. 484-485
|
artikel
|
| 61 |
Navigating Nomograms To Identify Prostate Cancer Patients for Lymph Node Dissection
|
Karakiewicz, Pierre I.
|
|
|
|
6 |
p. 564-565
|
artikel
|
| 62 |
Neoadjuvant Chemotherapy Does Not Increase the Morbidity of Radical Cystectomy: A 10-year Retrospective Nationwide Study
|
Salminen, Antti P.
|
|
|
|
6 |
p. 525-530
|
artikel
|
| 63 |
Neoadjuvant Chemotherapy or Immunotherapy for Clinical T2N0 Muscle-invasive Bladder Cancer: Time to Change the Paradigm?
|
Pederzoli, Filippo
|
|
|
|
6 |
p. 1006-1010
|
artikel
|
| 64 |
Oncological Outcomes for Patients with European Association of Urology Very High-risk Non–muscle-Invasive Bladder Cancer Treated with Bacillus Calmette-Guérin or Early Radical Cystectomy
|
Contieri, Roberto
|
|
|
|
6 |
p. 590-596
|
artikel
|
| 65 |
Opening a Scan of Worms
|
Davis, Ian D.
|
|
|
|
6 |
p. 725-727
|
artikel
|
| 66 |
Patterns of Cancer Progression of Metastatic Hormone-sensitive Prostate Cancer in the ECOG3805 CHAARTED Trial
|
Bryce, Alan H.
|
|
|
|
6 |
p. 717-724
|
artikel
|
| 67 |
Perioperative Complications and Oncologic Outcomes of Nephrectomy Following Immune Checkpoint Inhibitor Therapy: A Multicenter Collaborative Study
|
Yip, Wesley
|
|
|
|
6 |
p. 604-610
|
artikel
|
| 68 |
Phase I/II Trial of the Combination of 177Lutetium Prostate specific Membrane Antigen 617 and Idronoxil (NOX66) in Men with End-stage Metastatic Castration-resistant Prostate Cancer (LuPIN)
|
Crumbaker, Megan
|
|
|
|
6 |
p. 963-970
|
artikel
|
| 69 |
Phase II Trial of Enzalutamide and Androgen Deprivation Therapy with Salvage Radiation in Men with High-risk Prostate-specific Antigen Recurrent Prostate Cancer: The STREAM Trial
|
Bitting, Rhonda L.
|
|
|
|
6 |
p. 948-954
|
artikel
|
| 70 |
Phase 2 Multicenter Trial of Heterogeneous-dosing Stereotactic Body Radiotherapy for Low- and Intermediate-risk Prostate Cancer: 5-year Outcomes
|
Fuller, Donald B.
|
|
|
|
6 |
p. 540-547
|
artikel
|
| 71 |
Poor Outcomes for Patients with Metastatic Castration-resistant Prostate Cancer with Low Prostate-specific Membrane Antigen (PSMA) Expression Deemed Ineligible for 177Lu-labelled PSMA Radioligand Therapy
|
Thang, Sue Ping
|
|
|
|
6 |
p. 670-676
|
artikel
|
| 72 |
Predicting Oncologic Outcomes in Small Renal Tumors
|
Kapur, Payal
|
|
|
|
6 |
p. 687-694
|
artikel
|
| 73 |
Predictors of Recurrence After Metastasis-directed Therapy in Oligorecurrent Prostate Cancer Following Radical Prostatectomy
|
Milenkovic, Uros
|
|
|
|
6 |
p. 582-589
|
artikel
|
| 74 |
Prognostic Association of Prostate-specific Antigen Decline with Clinical Outcomes in Men with Metastatic Castration-resistant Prostate Cancer Treated with Enzalutamide in a Randomized Clinical Trial
|
Armstrong, Andrew J.
|
|
|
|
6 |
p. 677-684
|
artikel
|
| 75 |
Prognostic Implications of Multiparametric Magnetic Resonance Imaging and Concomitant Systematic Biopsy in Predicting Biochemical Recurrence After Radical Prostatectomy in Prostate Cancer Patients Diagnosed with Magnetic Resonance Imaging–targeted Biopsy
|
Gandaglia, Giorgio
|
|
|
|
6 |
p. 739-747
|
artikel
|
| 76 |
Prostate Imaging after Focal Ablation (PI-FAB): A Proposal for a Scoring System for Multiparametric MRI of the Prostate After Focal Therapy
|
Giganti, Francesco
|
|
|
|
6 |
p. 629-634
|
artikel
|
| 77 |
Prostate Magnetic Resonance Imaging for Local Recurrence Reporting (PI-RR): International Consensus -based Guidelines on Multiparametric Magnetic Resonance Imaging for Prostate Cancer Recurrence after Radiation Therapy and Radical Prostatectomy
|
Panebianco, Valeria
|
|
|
|
6 |
p. 868-876
|
artikel
|
| 78 |
Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography–based Lymph Node Atlas for Salvage Radiotherapy in Patients with Recurrent Prostate Cancer: A Validation of the New NRG Oncology 2020 guideline
|
Vogel, Marco M.E.
|
|
|
|
6 |
p. 668-676
|
artikel
|
| 79 |
Quality Assessment of Intraoperative Adverse Event Reporting During 29 227 Robotic Partial Nephrectomies: A Systematic Review and Cumulative Analysis
|
Cacciamani, Giovanni E.
|
|
|
|
6 |
p. 780-783
|
artikel
|
| 80 |
Quality Goal for Salvage Treatment for Patients with Prostate Cancer at Prostate-specific Antigen Relapse
|
von Eyben, Rie
|
|
|
|
6 |
p. 732-733
|
artikel
|
| 81 |
Radiation-based Therapy for Muscle-invasive Bladder Cancer: Contemporary Outcomes Across Tertiary Centers
|
Kool, Ronald
|
|
|
|
6 |
p. 597-603
|
artikel
|
| 82 |
Rationale and Outcomes for Neoadjuvant Immunotherapy in Urothelial Carcinoma of the Bladder
|
Rouanne, Mathieu
|
|
|
|
6 |
p. 728-738
|
artikel
|
| 83 |
Re: Ashley M. Hopkins, Ganessan Kichenadasse, Christos S. Karapetis, et al. Concomitant Proton Pump Inhibitor Use and Survival in Urothelial Carcinoma Treated with Atezolizumab. Clin Cancer Res. In press. https://doi.org/10.1158/1078-0432.CCR-20-1876
|
Funada, Satoshi
|
|
|
|
6 |
p. 807-808
|
artikel
|
| 84 |
Rectal Injury During Radical Prostatectomy: Focus on Robotic Surgery
|
Canda, Abdullah Erdem
|
|
|
|
6 |
p. 507-509
|
artikel
|
| 85 |
Recurrent Ta Low-grade Non-muscle-invasive Bladder Cancer: What Are the Options?
|
Rouprêt, Morgan
|
|
|
|
6 |
p. 723-729
|
artikel
|
| 86 |
Re: David Pasquier, Thomas Lacornerie, Stéphane Supiot, et al. The Safety and Efficacy of Salvage Stereotactic Radiation Therapy in Patients with Intraprostatic Tumor Recurrence After Previous External Radiation Therapy: Phase 1 Results from the GETUG-AFU 31 Study. Eur Urol Oncol. Eur Urol Oncol. 2023;6:399–405
|
Grivas, Nikolaos
|
|
|
|
6 |
p. 640
|
artikel
|
| 87 |
Re: Karl H. Tully, David-Dan Nguyen, Peter Herzog, et al. Risk of Dementia and Depression in Young and Middle-aged Men Presenting with Nonmetastatic Prostate Cancer Treated with Androgen Deprivation Therapy. Eur Urol Oncol. In press. http://dx.doi.org/10.1016/j.euo.2019.08.003
|
Fragkoulis, Charalampos
|
|
|
|
6 |
p. 809-810
|
artikel
|
| 88 |
Re: Madhuri Koti, Molly A. Ingersoll, Shilpa Gupta, et al. Sex Differences in Bladder Cancer Immunobiology and Outcomes: A Collaborative Review with Implications for Treatment. Eur Urol Oncol 2020;3:622–30
|
Alfano, Massimo
|
|
|
|
6 |
p. 802-803
|
artikel
|
| 89 |
Re: Maha Hussain, Joaquin Mateo, Karim Fizazi, et al. Survival with Olaparib in Metastatic Castration-resistant Prostate Cancer. N Engl J Med. In press. https://doi.org/10.1056/NEJMoa2022485
|
Rizzo, Alessandro
|
|
|
|
6 |
p. 806
|
artikel
|
| 90 |
Re: Nizar M. Tannir, Sabina Signoretti, Toni K. Choueiri, et al. Efficacy and Safety of Nivolumab Plus Ipilimumab versus Sunitinib in First-line Treatment of Patients with Advanced Sarcomatoid Renal Cell Carcinoma. Clin Cancer Res. In press. https://doi.org/10.1158/1078-0432.ccr-20-2063
|
Rizzo, Alessandro
|
|
|
|
6 |
p. 804-805
|
artikel
|
| 91 |
Reply to Anwar R. Padhani, Ivo G. Schoots, Jelle O. Barentsz. Fast Magnetic Resonance Imaging as a Viable Method for Directing the Prostate Cancer Diagnostic Pathway. Eur Urol Oncol 2021;4:863–5
|
Russo, Filippo
|
|
|
|
6 |
p. 866-867
|
artikel
|
| 92 |
Reply to Daniel D. Shapiro, Jose A. Karam, Viraj A. Master, et al.’s Letter to the Editor re: Wesley Yip, Alireza Ghoreifi, Thomas Gerald, et al. Perioperative Complications and Oncologic Outcomes of Nephrectomy Following Immune Checkpoint Inhibitor Therapy: A Multicenter Collaborative Study. Eur Urol Oncol. Eur Urol. Onc. 2023;604–610
|
Yip, Wesley
|
|
|
|
6 |
p. 637
|
artikel
|
| 93 |
Re: Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography–based Lymph Node Atlas for Salvage Radiotherapy in Patients with Recurrent Prostate Cancer: A Validation of the New NRG Oncology 2020 Guideline
|
Gandaglia, Giorgio
|
|
|
|
6 |
p. 635-636
|
artikel
|
| 94 |
Re: Wesley Yip, Alireza Ghoreifi, Thomas Gerald, et al. Perioperative Complications and Oncologic Outcomes of Nephrectomy Following Immune Checkpoint Inhibitor Therapy: A Multicenter Collaborative Study. Eur Urol Oncol. Eur Urol. Onc. 2023;604–610
|
Shapiro, Daniel D.
|
|
|
|
6 |
p. 638-639
|
artikel
|
| 95 |
Selecting the Best Candidates for Cisplatin-based Adjuvant Chemotherapy After Radical Cystectomy Among Patients with pN+ Bladder Cancer
|
Afferi, Luca
|
|
|
|
6 |
p. 722-725
|
artikel
|
| 96 |
Sentinel Node Identification with Hybrid Tracer-guided and Conventional Dynamic Sentinel Node Biopsy in Penile Cancer: A Prospective Study in 130 Patients from the Two National Referral Centres in Sweden
|
Torbrand, Christian
|
|
|
|
6 |
p. 704-711
|
artikel
|
| 97 |
Sequencing of Taxanes and New Androgen-targeted Therapies in Metastatic Castration-resistant Prostate Cancer: Results of the International Multicentre Retrospective CATS Database
|
Delanoy, Nicolas
|
|
|
|
6 |
p. 467-475
|
artikel
|
| 98 |
Sex-specific Alterations in the Urinary and Tissue Microbiome in Therapy-naïve Urothelial Bladder Cancer Patients
|
Pederzoli, Filippo
|
|
|
|
6 |
p. 784-788
|
artikel
|
| 99 |
Somatic Features of Response and Relapse in Non–muscle-invasive Bladder Cancer Treated with Bacillus Calmette-Guérin Immunotherapy
|
Bacon, Jack V.W.
|
|
|
|
6 |
p. 677-686
|
artikel
|
| 100 |
Somatic HOXB13 Expression Correlates with Metastatic Progression in Men with Localized Prostate Cancer Following Radical Prostatectomy
|
Weiner, Adam B.
|
|
|
|
6 |
p. 955-962
|
artikel
|
| 101 |
Sorafenib Versus Observation Following Radical Metastasectomy for Clear-cell Renal Cell Carcinoma: Results from the Phase 2 Randomized Open-label RESORT Study
|
Procopio, Giuseppe
|
|
|
|
6 |
p. 699-707
|
artikel
|
| 102 |
Stereotactic Ablative Radiation for Systemic Therapy–naïve Oligometastatic Kidney Cancer
|
Hannan, Raquibul
|
|
|
|
6 |
p. 695-703
|
artikel
|
| 103 |
Stereotactic Body Radiotherapy for Oligometastatic Prostate Cancer Detected via Prostate-specific Membrane Antigen Positron Emission Tomography
|
Kneebone, Andrew
|
|
|
|
6 |
p. 531-537
|
artikel
|
| 104 |
Systematic Review of the Management of Local Kidney Cancer Relapse
|
Kriegmair, Maximilian C.
|
|
|
|
6 |
p. 512-523
|
artikel
|
| 105 |
The Role of Multiparametric Magnetic Resonance Imaging in Active Surveillance for Men with Low-risk Prostate Cancer: A Cost-effectiveness Modeling Study
|
Patel, Sejal
|
|
|
|
6 |
p. 476-483
|
artikel
|
| 106 |
Three-dimensional Model–assisted Minimally Invasive Partial Nephrectomy: A Systematic Review with Meta-analysis of Comparative Studies
|
Piramide, Federico
|
|
|
|
6 |
p. 640-650
|
artikel
|
| 107 |
Tissue- and Blood-derived Genomic Biomarkers for Metastatic Hormone-sensitive Prostate Cancer: A Systematic Review
|
Van der Eecken, Kim
|
|
|
|
6 |
p. 914-923
|
artikel
|
| 108 |
Towards a Better Understanding of Antibody-Drug Conjugates in Urothelial Carcinoma
|
Labaki, Chris
|
|
|
|
6 |
p. 719-721
|
artikel
|
| 109 |
Towards Biologically Driven Decision-making in Metastatic Hormone-sensitive Prostate Cancer
|
Beltran, Himisha
|
|
|
|
6 |
p. 924-926
|
artikel
|
| 110 |
Treatments for Metastatic Hormone-sensitive Prostate Cancer: Systematic Review, Network Meta-analysis, and Benefit-harm assessment
|
Menges, Dominik
|
|
|
|
6 |
p. 605-616
|
artikel
|
| 111 |
TROP2 Expression Across Molecular Subtypes of Urothelial Carcinoma and Enfortumab Vedotin-resistant Cells
|
Chou, Jonathan
|
|
|
|
6 |
p. 714-718
|
artikel
|
| 112 |
Unleashing the Power of Artificial Intelligence and Fusion Magnetic Resonance Imaging–Targeted Biopsy: Transforming Prostate Cancer Diagnosis
|
Lenfant, Louis
|
|
|
|
6 |
p. 541-542
|
artikel
|
| 113 |
What Is the Prognostic and Clinical Importance of Urothelial and Nonurothelial Histological Variants of Bladder Cancer in Predicting Oncological Outcomes in Patients with Muscle-invasive and Metastatic Bladder Cancer? A European Association of Urology Muscle Invasive and Metastatic Bladder Cancer Guidelines Panel Systematic Review
|
Veskimäe, Erik
|
|
|
|
6 |
p. 625-642
|
artikel
|
| 114 |
Who Benefits from Multiparametric Magnetic Resonance Imaging After Suspicion of Prostate Cancer?
|
Morote, Juan
|
|
|
|
6 |
p. 664-669
|
artikel
|
| 115 |
Will Dynamic Sentinel Lymph Node Biopsy Surpass Inguinal Lymph Node Dissection in High-risk Node-negative Penile Cancer?
|
Peak, Taylor
|
|
|
|
6 |
p. 712-713
|
artikel
|
Tijdschrift beschrijving